Vitamin D supplementation may improve back pain disability in vitamin D deficient and overweight or obese adults.


Journal

The Journal of steroid biochemistry and molecular biology
ISSN: 1879-1220
Titre abrégé: J Steroid Biochem Mol Biol
Pays: England
ID NLM: 9015483

Informations de publication

Date de publication:
01 2019
Historique:
received: 30 07 2018
revised: 05 09 2018
accepted: 06 09 2018
pubmed: 12 9 2018
medline: 15 5 2019
entrez: 12 9 2018
Statut: ppublish

Résumé

Back pain is currently the greatest cause of disability worldwide, and there are very limited therapeutic options available. Vitamin D deficiency and obesity are both risk factors for back pain. The few randomised controlled trials examining the effects of vitamin D supplementation on back pain have methodological limitations and largely include non-vitamin D deficient participants. Thus, the aim of this study was to determine whether vitamin D supplementation improves back pain symptoms in vitamin D deficient and overweight or obese, otherwise healthy adults. Sixty-five overweight or obese adults (BMI ≥ 25 kg/m

Identifiants

pubmed: 30201225
pii: S0960-0760(18)30435-7
doi: 10.1016/j.jsbmb.2018.09.005
pii:
doi:

Substances chimiques

Calcium-Regulating Hormones and Agents 0
Vitamin D 1406-16-2
Cholecalciferol 1C6V77QF41
25-hydroxyvitamin D A288AR3C9H

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

212-217

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Sharmayne R E Brady (SRE)

Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, Australia.

Negar Naderpoor (N)

Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, 43-51, Kanooka Grove, Clayton, VIC, 3168 Australia.

Maximilian P J de Courten (MPJ)

Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, Australia; Centre for Chronic Disease Prevention, Victoria University, Melbourne, VIC, 3021, Australia.

Robert Scragg (R)

School of Population Health, University of Auckland, Auckland, New Zealand.

Flavia Cicuttini (F)

Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, Australia.

Aya Mousa (A)

Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, 43-51, Kanooka Grove, Clayton, VIC, 3168 Australia.

Barbora de Courten (B)

Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, 43-51, Kanooka Grove, Clayton, VIC, 3168 Australia. Electronic address: barbora.decourten@monash.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH